Jupiter Investment Management’s West Pharmaceutical WST Stock Holding History

Jupiter Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17,305	Closed	-$2.63M	–	488
2020 Q1	$2.63M	Sell	17,305 -12,704	-42%	-$1.96M	0.05%	194
2019 Q4	$4.51M	Buy	+30,009	New	+$4.37M	0.06%	235
2017 Q2	–	Sell	-2,800	Closed	-$228K	–	492
2017 Q1	$228K	Buy	+2,800	New	+$234K	﹤0.01%	329
2014 Q3	–	Sell	-9,826	Closed	-$414K	–	409
2014 Q2	$414K	Sell	9,826 -22,544	-70%	-$965K	0.02%	281
2014 Q1	$1.43M	Sell	32,370 -1,951	-6%	-$91.8K	0.1%	199
2013 Q4	$1.68M	Buy	+34,321	New	+$1.61M	0.14%	181

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Jupiter Investment Management's WST Position: Q2 2020 in Review

Jupiter Investment Management sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 17,305 shares — an estimated $2.63M sold.

Jupiter Investment Management first reported a position in WST in Q4 2013 and held it in 6 quarters. The position peaked at $4.51M in Q4 2019. 523 funds tracked by Wall St. Rank hold WST as of Q2 2020.

Jupiter Investment Management reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
Jupiter Investment Management sold 17,305 West Pharmaceutical shares in Q2 2020, an estimated $2.63M.
Jupiter Investment Management first reported a position in West Pharmaceutical in Q4 2013 and held it in 6 quarters.
Jupiter Investment Management's West Pharmaceutical position peaked at $4.51M in Q4 2019.
523 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.